Skip to content

Evaluation of Antihypertensive Drugs in OSA Patients

Evaluation of Antihypertensive Drugs in Patients With Obstructive Sleep Apnea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01803815
Acronym
ADOSA
Enrollment
369
Registered
2013-03-04
Start date
2010-04-30
Completion date
2013-04-30
Last updated
2014-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Obstructive Sleep Apnea

Keywords

obstructive sleep apnea, hypertension, antihypertensive drugs

Brief summary

This prospective cohort study aimed to assess the phenotypic characteristics of OSA patients and their pattern of antihypertensive drugs consumption. The investigators also aimed to investigate a hypothetical association between ongoing anti-hypertensive regimen and Blood pressure control rates in these patients. Additionally, the investigators were also interested in trying to understand if the control of OSA may be influenced by the use of different classes of anti-hypertensive drugs.

Interventions

None listed

Sponsors

Universidade Nova de Lisboa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged above 18 years, that attended a first visit at CHLN Hospital Sleep Unit were enrolled

Exclusion criteria

* severe psychiatric disease or inability to understand the information required for an informed consent.

Design outcomes

Primary

MeasureTime frame
Number of participants with uncontrolled BP before CPAP (Continuous Positive Airway Pressure) adaptation.patients will be followed up for an expected average time of 2 months

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026